14-24172933-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001048205.2(REC8):āc.160C>Gā(p.Gln54Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000023 in 1,611,206 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001048205.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152200Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000610 AC: 15AN: 245856Hom.: 0 AF XY: 0.0000449 AC XY: 6AN XY: 133746
GnomAD4 exome AF: 0.0000117 AC: 17AN: 1458888Hom.: 0 Cov.: 33 AF XY: 0.00000413 AC XY: 3AN XY: 725874
GnomAD4 genome AF: 0.000131 AC: 20AN: 152318Hom.: 0 Cov.: 33 AF XY: 0.000148 AC XY: 11AN XY: 74474
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 14, 2024 | The c.160C>G (p.Q54E) alteration is located in exon 3 (coding exon 3) of the REC8 gene. This alteration results from a C to G substitution at nucleotide position 160, causing the glutamine (Q) at amino acid position 54 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at